Utilisation of Telemedicine in Optimal Cardiac Rehabilitation Program in Patients After Myocardial Revascularization
RESTORE
The Use of Modern Telemedicine Technologies in an Innovative Program of Optimal Cardiac Rehabilitation in Patients After Completed Myocardial Revascularization
1 other identifier
interventional
1,000
1 country
5
Brief Summary
Although clinical data demonstrate advantages of combining complete revascularization with optimal cardiac rehabilitation (CR) less than one-third of patients in European countries participate in cardiac rehabilitation programs. Therefore, in cooperation with Polish leaders in cardiovascular medicine, rehabilitation and medical software design we aim to introduce and evaluate the system of optimal cardiac telerehabilitation in addition to optimal treatment of coronary artery disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2018
Typical duration for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2017
CompletedFirst Posted
Study publicly available on registry
December 18, 2017
CompletedStudy Start
First participant enrolled
March 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedMay 30, 2018
May 1, 2018
1.7 years
December 12, 2017
May 28, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
All cause mortality
The primary objective of the study is to compare the all cause mortality between the control and the study group during the annual follow-up.
12 months
All cause mortality
The primary objective of the study is to compare the all cause mortality between the control and the study group during the 9-month follow-up.
9 months
Secondary Outcomes (6)
Rate of major adverse coronary and cerebrovascular events (MACCE)
9 months and 1 year
rate of target vessel failure (TVF)
9 months and 1 year
cardiac death
9 months and 1 year
Length of hospital stay
up to 9 months and 1 year
Regression, stabilisation or progression of atherosclerotic plaques
baseline + up to 1 year follow-up
- +1 more secondary outcomes
Study Arms (2)
control group
NO INTERVENTIONCardiac supervision
study group
OTHERCardiac supervision and rehabilitation
Interventions
The purpose of this work package is to evaluate short- and long-term clinical effects of optimal, continuous and regularly controlled tele-rehabilitation, which is based on exercise training, intensive dietary and educational program focused on lifestyle and risk factors modification. The main expectations of OCR is to normalize annual mortality to the level of the low risk "healthy" population.
Eligibility Criteria
You may qualify if:
- age over 18 and below 70
- completed revascularization in patients with stable or unstable angina or after myocardial infarction without ST-segment elevation (NSTEMI)
- in patients with suspected myocardial scars, MRI will be recommended to confirm myocardial viability.
- eligibility to participate in a program of early cardiac rehabilitation
- signed informed consent form
- the ability to use telerehabilitation system
You may not qualify if:
- acute myocardial infarction with ST segment elevation/new onset of left bundle branch block (LBBB),
- suboptimal (not completed) revascularisation
- ejection fraction \<40%.
- acute heart failure (Killip IV) at the time of admission to the hospital
- dual antiplatelet therapy can not be maintained for 1 year after PCI
- haemorrhagic stroke in the past
- ischemic stroke or transient ischemia in previous 6 weeks
- platelet count \<100,000 / mm3
- chronic renal failure with creatinine clearance \<30ml / min / 1.73m2
- planned surgery
- pregnancy or planned pregnancies
- expected life expectancy less than 3 years after enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pawel Buszmanlead
Study Sites (5)
Malopolskie Centrum Sercowo-Naczyniowe
Chrzanów, Lesser Poland Voivodeship, 32-500, Poland
IV Oddział Kardiologii Inwazyjnej, Elektrostymulacji i Angiologii
Kedzierzyn Kozle, Lower Silesian Voivodeship, 47-200, Poland
II Oddział Kardiologiczny
Bielsko-Biala, Upper Silesia, 43-316, Poland
III Oddział Kardiologii Inwazyjnej, Angiologii i Elektrokardiologii
Dąbrowa Górnicza, Upper Silesia, 41-300, Poland
X Department of Interventional Cardiology
Tychy, Upper Silesia, 43-100, Poland
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Krzysztof Milewski, MD PhD
American Heart of Poland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chief Executive Officer
Study Record Dates
First Submitted
December 12, 2017
First Posted
December 18, 2017
Study Start
March 28, 2018
Primary Completion
December 1, 2019
Study Completion
July 1, 2020
Last Updated
May 30, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share